KYNMOBI

Peak

apomorphine hydrochloride

Sumitomo Dainippon Pharma
NDASUBLINGUALFILM
Approved
May 2020
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Apr 19, 2036
123 months away
Patent Expiry
Apr 19, 2036

Patent Records (5)

Patent #ExpiryTypeUse Code
10821074
Aug 7, 2029
Product
—
10420763
Jun 11, 2030
Product
U-2825
9044475
Jun 11, 2030
Product
—
9283219
Jun 11, 2030
Product
U-2825
9326981
Jun 11, 2030
U-2825
Company
SD
Sumitomo Dainippon Pharma
Japan - Oita
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers